Screener
Apogee Therapeutics, Inc. APGE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | MARCH 31,2026 | DECEMBER 31,2025 |
|---|---|---|
| Cash and cash equivalents | $451,797 | $131,549 |
| Marketable securities | 608,088 | 598,643 |
| Prepaid expenses and other current assets | 13,912 | 11,166 |
| Total current assets | 1,073,797 | 741,358 |
| Long-term marketable securities | 198,354 | 172,730 |
| Property and equipment, net | 5,280 | 5,688 |
| Right-of-use asset, net | 7,707 | 8,687 |
| Other non-current assets | 8,516 | 8,671 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s total current assets?
- Apogee Therapeutics, Inc. (APGE) reported total current assets of $1.07B in Q1 2026.
- How has Apogee Therapeutics, Inc.'s total current assets changed year-over-year?
- Apogee Therapeutics, Inc.'s total current assets increased by 105.9% year-over-year, from $521.53M to $1.07B.
- What is the long-term trend for Apogee Therapeutics, Inc.'s total current assets?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s total current assets has grown at a 69.6% compound annual growth rate (CAGR), from $152.06M to $741.36M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Apogee Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude